FDA Adverse Event Injury Summary report: N

REFLEXION MEDICAL RADIOTHERAPY SYSTEM

MDR report key: 24760478 · Received April 1, 2026

Report

Report Number
3011716550-2026-00020
Event Type
Injury
Date Received
April 1, 2026
Date of Event
March 6, 2025
Report Date
April 1, 2026
Manufacturer
REFLEXION MEDICAL INC
Product Code
QVA
UDI-DI
00860003983812
PMA / PMN Number
DEN220014
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A RECALL HAS BEEN FILED FOR THIS ISSUE ON 12-FEB-2026 (RES# 98518, RECALL NUMBER: Z-1656-2026, REFLEXION REPORT#: 3011716550-02122026-C-00001). REFLEXION CONTINUES TO WORK WITH THE SITE TO COMPLETE THE INVESTIGATION INTO POTENTIAL EVENTS. REFLEXION HAS COMPLETED THE ROOT CAUSE INVESTIGATION FOR THE CAPA OPENED AND IS IN THE PROCESS OF IMPLEMENTING THE PROPOSED SOLUTION.

Description of Event or Problem · 0

DURING ROUTINE TESTING OF THE REFLEXION MEDICAL RADIOTHERAPY SYSTEM (RMRS) ON SITE AT REFLEXION, THE FOLLOWING FAILURE MODE WAS IDENTIFIED. WHEN PERFORMING ANGULAR ROLL CORRECTIONS FOLLOWED BY A REPEAT LOCALIZATION, THE ROLL CORRECTIONS APPLIED IN THE INITIAL LOCALIZATION SCAN ARE NOT CARRIED THROUGH TO TREATMENT DELIVERY LEADING TO THE TREATMENT PLAN DOSE BEING DELIVERED TO THE INCORRECT LOCATION. THIS WAS DETERMINED TO BE THE RESULT OF A SOFTWARE DEFECT ASSOCIATED WITH THE CALCULATION AND COMMUNICATION OF CUMULATIVE VIRTUAL ROLL OFFSETS BETWEEN COMPONENTS IN THE SYSTEM. IT WAS DETERMINED THAT A VERY SMALL NUMBER OF AFFECTED TREATMENT SESSIONS MAY HAVE A DISPLACEMENT OF AS MUCH AS 5MM FROM THE INTENDED LOCATION FOR THE DELIVERED DOSE VOLUME. A DISPLACEMENT OF 5MM OR HIGHER MAY RESULT IN CLINICALLY SIGNIFICANT DOSIMETRIC ERRORS (POTENTIALLY AS HIGH AS 10% TO 20% UNDERDOSE). USING INFORMATION AVAILABLE IN THE SYSTEM LOGS TO INVESTIGATE THE IMPACT OF THE ABOVE PROBLEM, THE FOLLOWING CASE WAS IDENTIFIED AS MEETING A GREATER THAN 5MM DISPLACEMENT REPRESENTING A POTENTIALLY SIGNIFICANT DOSIMETRIC ERROR. THE PATIENT PLAN CONSISTED OF 30 GY TO BE DELIVERED IN 5 FRACTIONS, WITH A 6 GY PLAN DOSE PER FRACTION. IN 1 OF 5 FRACTIONS FOR THIS SPECIFIC CASE, A POTENTIAL DOSE DISPLACEMENT OF 5.5MM WAS IDENTIFIED. THE SITE'S CLINICAL TEAM, WITH ACCESS TO ALL THE TREATMENT INFORMATION (E.G., DOSE DISTRIBUTION, TARGET LOCATION, PROXIMITY OF NEARBY ORGANS AT RISK, ETC.) EVALUATED THE CASE AND DETERMINED THAT NO ACTUAL SERIOUS INJURY OCCURRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
822341 REFLEXION MEDICAL RADIOTHERAPY SYSTEM RXM1000 QVA REFLEXION MEDICAL INC RXM1000 00860003983812

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown